CBA Florida Inc. (fka CBAI)

[MrLong]

DWHP Blood Pharming:
If CBAI is the owner of stem cells from default accounts it has acquired from past deals then the Arteriocyte machine can take 1 bag of ucb and expand it to 20 pints.

FoxNews Reports:
Now, you could also harvest cells through a similar technique by filtering them peripherally from a pint of blood, where stem cells similar to those in bone marrow are circulating in the blood stream.
All of these stem cells have the potential to either treat damaged tissue from a heart attack, or even develop into new tissue that regenerates organs we need that may begin to fail as we get older.
Read more: http://www.foxnews.com/health/2011/01/05/stem-cells-help-dick-cheney/#ixzz1BTvMg1vm

1)DWHP makes 20 pints of universal O-Neg blood from one cord blood bag. According to the report isn't this expanding the stems if the yield is 20 fold? Is the plan to manufacture and extract cells in this 1:20 ratio from O-Neg synthetic blood?

2)If you manufacture O-Neg synthetic blood you also eliminate GvHD! Right? That means any drug manufactured from O-Neg no longer has a GvHD issue. Right?

3)Is this something the Red Cross would want in on?

If CBAI is sitting on 50k stems those private stem owners defaulted payment on from these acquisition companies that were not profitable - then those acquired stem contract assets are worth a lot of money to there new owner - CBAI. Right? The assets in cold storage in Vegas (today), if +50k, aren't making a dime - there isn't an annuity payment if CBAI shareholders are the owners. Has this been the plan and would account for the slow revs picture in 2010; yet there are 25 dewars in Vegas today?

RGI IVF was dumped out of the hESC experiment because the donor contract language wasn't good enough when the NIH reviewed it.

CBAI acquired contracts in it acquisitions. If a person defaults by walking away and abandons their property and company A spent a lot of costs upfront to get that contract that model dies. Company B (CBAI) comes in and buys the default contracts for less than $200/per and is now the new owner of said default contract that made company A fail or not profitable then who is wiser. CBAI, the entity that makes the purchase of those assets knowing DW/OSiris needs those CBAI Acquired Contract Stems for therapies. Right? Are we about to become profitable from the sale of those acquired default contracts?

This method of acquiring those stems, maybe +50k over the past 5 yrs computes. Has CBAI created its own unrelated donor tank at <$200/stem? If true, it did so with Shareholder monies and if true it is cheaper than the NMDP model at $22,500 to bank 1 stem right?

This is how I see $100 pps in 2011 - time to resell those stems. Is this the plan?

DWHP, Osiris need stems from a donor tank to do their business; hence the Osiris donor MSC form. CBAI shareholders aren't making annuity payments (CBAI revs) from stems they acquired that are now owned by CBAI is my theory. There are 25 dewars in Vegas today likely filled with acquired stems waiting to matched up with DW and Osiris needs.

What the CEO said that I found interesting in the recent MoneyTV interview is a recent test determined cell viability in cool storage exceeded 20 yrs and that his scientists believe it is possible for them to remain viable for a lifetime. Are a majority of stems in Vegas today not generating any annuity revenue because investors acquired those stems from failing businesses whereby the owners walked away and abandoned those contracts? This scenario fits the current revs picture from Jan 2010 - present imo and explains how we have 25 dewars w/o a change in revs.

Is the plan now to sell the stems like a donor bank but our customer is commercial DW/Osiris?